• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断乳腺癌患者的高胰岛素水平反映了潜在的胰岛素抵抗,并与胰岛素抵抗综合征的组成部分相关。

High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.

作者信息

Goodwin Pamela J, Ennis Marguerite, Bahl Mala, Fantus I George, Pritchard Kathleen I, Trudeau Maureen E, Koo Jarley, Hood Nicky

机构信息

Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Avenue, Toronto, ON, Canada M5G 1X5.

出版信息

Breast Cancer Res Treat. 2009 Apr;114(3):517-25. doi: 10.1007/s10549-008-0019-0. Epub 2008 Apr 25.

DOI:10.1007/s10549-008-0019-0
PMID:18437560
Abstract

BACKGROUND

High insulin levels have been associated with poor outcomes in breast cancer. Our goal was to investigate whether hyperinsulinemia was associated with insulin resistance in a cohort of newly diagnosed locoregional breast cancer patients and to examine associations of hyperinsulinemia with the broader insulin resistance syndrome (IRS).

METHODS

Five hundred and four women with T1-3, N0-1, M0 breast cancer provided fasting blood that was analyzed for glucose, insulin and lipids. They underwent anthropomorphic measurements and provided information on diet, exercise and sleep. Relationships of insulin with three validated indices of insulin resistance and with attributes of the IRS were examined.

RESULTS

High insulin levels were strongly correlated with insulin resistance calculated using the three indices of insulin resistance/sensitivity (Spearman r=0.83-0.98). Hyperinsulinemia was also associated with other components of the IRS (obesity, high waist-hip ratio, lipid profile).

CONCLUSIONS

High insulin levels in women with locoregional breast cancer reflect the presence of insulin resistance and are associated with other components of the IRS. These observations have implications for the development of therapies that target hyperinsulinemia in early stage breast cancer and for the long-term management of breast cancer survivors.

摘要

背景

高胰岛素水平与乳腺癌预后不良相关。我们的目标是在一组新诊断的局部区域乳腺癌患者中研究高胰岛素血症是否与胰岛素抵抗相关,并探讨高胰岛素血症与更广泛的胰岛素抵抗综合征(IRS)之间的关联。

方法

504名患有T1 - 3、N0 - 1、M0期乳腺癌的女性提供了空腹血液,用于分析血糖、胰岛素和血脂。她们接受了人体测量,并提供了有关饮食、运动和睡眠的信息。研究了胰岛素与三种经过验证的胰岛素抵抗指标以及与IRS特征之间的关系。

结果

高胰岛素水平与使用三种胰岛素抵抗/敏感性指标计算出的胰岛素抵抗密切相关(斯皮尔曼r = 0.83 - 0.98)。高胰岛素血症还与IRS的其他组成部分(肥胖、高腰臀比、血脂谱)相关。

结论

局部区域乳腺癌女性的高胰岛素水平反映了胰岛素抵抗的存在,并与IRS的其他组成部分相关。这些观察结果对针对早期乳腺癌高胰岛素血症的治疗方法的开发以及乳腺癌幸存者的长期管理具有重要意义。

相似文献

1
High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.新诊断乳腺癌患者的高胰岛素水平反映了潜在的胰岛素抵抗,并与胰岛素抵抗综合征的组成部分相关。
Breast Cancer Res Treat. 2009 Apr;114(3):517-25. doi: 10.1007/s10549-008-0019-0. Epub 2008 Apr 25.
2
Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.血清脂质与早期乳腺癌的预后:一项前瞻性队列研究的结果
Breast Cancer Res Treat. 2005 Nov;94(2):135-44. doi: 10.1007/s10549-005-6654-9.
3
SHBG levels correlate with insulin resistance in postmenopausal women.绝经后女性的性激素结合球蛋白(SHBG)水平与胰岛素抵抗相关。
Eur J Intern Med. 2009 Mar;20(2):162-7. doi: 10.1016/j.ejim.2007.09.023. Epub 2008 Jul 30.
4
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.混合力量与耐力运动干预对乳腺癌幸存者胰岛素水平的影响。
J Clin Oncol. 2008 Feb 20;26(6):907-12. doi: 10.1200/JCO.2007.12.7357.
5
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.代谢综合征、中心性肥胖和胰岛素抵抗与绝经后乳腺癌的不良病理特征相关。
Clin Oncol (R Coll Radiol). 2010 May;22(4):281-8. doi: 10.1016/j.clon.2010.02.001. Epub 2010 Feb 26.
6
Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.可溶性细胞间黏附分子-1与台湾人群胰岛素抵抗及代谢综合征的关联。
Metabolism. 2009 Jul;58(7):983-8. doi: 10.1016/j.metabol.2009.02.021.
7
Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome.患有和未患有代谢综合征的冠心病患者血浆中n-3和n-6脂肪酸水平与胰岛素抵抗的关系。
Nutr Metab Cardiovasc Dis. 2009 May;19(4):264-70. doi: 10.1016/j.numecd.2008.07.008. Epub 2008 Sep 20.
8
The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity.代谢综合征的血液流变学方面是胰岛素抵抗、高胰岛素血症和肥胖各自作用的综合结果。
Clin Hemorheol Microcirc. 2006;35(1-2):113-9.
9
The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.绝经后乳腺癌患者中胰岛素抵抗和代谢综合征与已知乳腺癌预后因素的关系。
J BUON. 2013 Oct-Dec;18(4):845-50.
10
Increased prevalence of prior breast cancer in women with newly diagnosed diabetes.新诊断糖尿病女性中既往乳腺癌患病率增加。
Breast Cancer Res Treat. 2006 Aug;98(3):303-9. doi: 10.1007/s10549-006-9166-3. Epub 2006 Mar 15.

引用本文的文献

1
The Impact and Safety of GLP-1 Agents and Breast Cancer.胰高血糖素样肽-1(GLP-1)受体激动剂与乳腺癌的影响及安全性
Cancer Med. 2025 Jun;14(12):e70932. doi: 10.1002/cam4.70932.
2
The prognostic impact of body mass index in breast cancer according to tumor subtype.根据肿瘤亚型分析体重指数对乳腺癌的预后影响。
Korean J Clin Oncol. 2023 Dec;19(2):52-59. doi: 10.14216/kjco.23010. Epub 2023 Dec 31.
3
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.体重指数对乳腺癌患者新辅助化疗反应的预测重要性
Breast Care (Basel). 2023 Feb;18(1):42-48. doi: 10.1159/000526732. Epub 2022 Sep 14.
4
Nomogram model for the risk of insulin resistance in obese children and adolescents based on anthropomorphology and lipid derived indicators.基于人体测量学和脂质衍生指标的肥胖儿童和青少年胰岛素抵抗风险的列线图模型。
BMC Public Health. 2023 Feb 7;23(1):275. doi: 10.1186/s12889-023-15181-1.
5
An Overview of the Impact of Body Mass Index on Pathological Complete Response Following Neoadjuvant Chemotherapy in Operable Breast Cancer in a Tertiary Care Centre in South India.印度南部一家三级医疗中心中体重指数对可手术乳腺癌新辅助化疗后病理完全缓解影响的概述
Eur J Breast Health. 2022 Jul 1;18(3):271-278. doi: 10.4274/ejbh.galenos.2022.2022-2-5. eCollection 2022 Jul.
6
The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial.二甲双胍对接受新辅助化疗的局部晚期乳腺癌患者结局的影响:一项开放标签随机对照试验。
Sci Rep. 2022 May 10;12(1):7656. doi: 10.1038/s41598-022-11138-3.
7
Obesity, Diabetes, and Increased Cancer Progression.肥胖、糖尿病与癌症恶化。
Diabetes Metab J. 2021 Nov;45(6):799-812. doi: 10.4093/dmj.2021.0077. Epub 2021 Nov 22.
8
Identification of a Prognostic Signature Based on the Expression of Genes Related to the Insulin Pathway in Early Breast Cancer.基于早期乳腺癌胰岛素通路相关基因表达的预后特征识别
Breast Care (Basel). 2021 Jun;16(3):299-306. doi: 10.1159/000509207. Epub 2020 Aug 28.
9
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis.体质量指数对可手术乳腺癌新辅助化疗后病理完全缓解的影响:一项荟萃分析。
Breast Cancer. 2021 May;28(3):618-629. doi: 10.1007/s12282-020-01194-w. Epub 2021 Jan 2.
10
Implications of metabolism-driven myeloid dysfunctions in cancer therapy.代谢驱动的髓系功能障碍在癌症治疗中的意义。
Cell Mol Immunol. 2021 Apr;18(4):829-841. doi: 10.1038/s41423-020-00556-w. Epub 2020 Oct 19.